HomeCompareKBA vs JNJ

KBA vs JNJ: Dividend Comparison 2026

KBA yields 1.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBA wins by $2.0K in total portfolio value
10 years
KBA
KBA
● Live price
1.60%
Share price
$30.26
Annual div
$0.48
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$177.07
Full KBA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KBA vs JNJ

📍 KBA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KBA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBA
Annual income on $10K today (after 15% tax)
$135.72/yr
After 10yr DRIP, annual income (after tax)
$150.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $553.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBA + JNJ for your $10,000?

KBA: 50%JNJ: 50%
100% JNJ50/50100% KBA
Portfolio after 10yr
$21.0K
Annual income
$502.42/yr
Blended yield
2.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KBA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBA buys
0
JNJ buys
0
No recent congressional trades found for KBA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBAJNJ
Forward yield1.60%3.36%
Annual dividend / share$0.48$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$22.0K$20.0K
Annual income after 10y$177.07$827.78
Total dividends collected$1.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KBA vs JNJ ($10,000, DRIP)

YearKBA PortfolioKBA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,860$159.67$10,676$355.77+$184.00KBA
2$11,782$162.05$11,407$389.39+$375.00KBA
3$12,771$164.31$12,198$426.53+$573.00KBA
4$13,831$166.45$13,056$467.62+$775.00KBA
5$14,968$168.48$13,987$513.12+$981.00KBA
6$16,186$170.40$14,998$563.56+$1.2KKBA
7$17,491$172.21$16,098$619.52+$1.4KKBA
8$18,890$173.92$17,295$681.69+$1.6KKBA
9$20,388$175.54$18,599$750.82+$1.8KKBA
10$21,992$177.07$20,022$827.78+$2.0KKBA

KBA vs JNJ: Complete Analysis 2026

KBAStock

Under normal circumstances, the fund will invest at least 80% of its net assets in securities of the underlying index and other instruments that have economic characteristics similar to such securities, including depositary receipts. The underlying index reflects the large- and mid-cap Chinese renminbi (“RMB”)-denominated equity securities listed on the Shenzhen or Shanghai Stock Exchanges (“A-Shares”) that are accessible through the Shanghai-Hong Kong Stock Connect or Shenzhen-Hong Kong Stock Connect programs.

Full KBA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KBA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBA vs SCHDKBA vs JEPIKBA vs OKBA vs KOKBA vs MAINKBA vs ABBVKBA vs MRKKBA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.